Effectiveness and cost-effectiveness of interferon beta and glatiramer acetate in the UK Multiple Sclerosis Risk Sharing Scheme at 6 years: a clinical cohort study with natural history comparator

Authors:

Abstract
No abstract available
Funding Information
  • Health Technology Assessment Programme (10/55/01)
  • National Multiple Sclerosis Society
  • Canadian Institutes of Health Research
  • MS Canada

This publication has 29 references indexed in Scilit: